The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
Zomedica will sponsor a variety of high-profile events within the USEA ANN ARBOR, MI / ACCESSWIRE / July 17, 2024...
Diagnostics
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity
After four weeks of treatment, CT-996 demonstrated clinically meaningful weight loss of -7.3% (weight loss in placebo -1.2%; p <...
Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader...
Teknova Announces Closing of $15.4 Million Private Placement
HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Teknova Announces $15.4 Million Private Placement
HOLLISTER, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents...
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
SEATTLE, July 11, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.
Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery. WILMINGTON, Del. ,...
Vendor Neutral Archive (VNA) Market to be Worth USD 1.3 billion by 2034, Growing a CAGR 12.6% – Exclusive Report by Transparency Market Research, Inc.
The improvement of patient care and compliance is expected to drive demand for a vendor-neutral archive market. A growing concern...
Lucid Diagnostics Launches New Corporate Website
NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics...
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC
SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry...
Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and...
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
SAN DIEGO, July 11, 2024 /PRNewswire/ -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced over $277...
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic...
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
LONDON and NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in...
Hydreight Expands Its “At-Home Blood Testing” Solution with More Tests to All 50 States
In a joint-venture with a national laboratory, Hydreight and its medical network are expanding at-home lab tests spanning a range...
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential
Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001...
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals
MELBOURNE, Australia, July 11, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes proposed changes...
Persana Launches, Revolutionizing Aesthetic Health
Renowned and In-Demand, Peer-Vetted Aesthetic Physicians Now Accessible Via New Virtual Gateway, Persana LOS ANGELES, July 10, 2024 /PRNewswire/ -- Persana,...
Force Therapeutics Awarded by Newsweek’s World’s Best Digital Health Companies 2024
NEW YORK, July 10, 2024 /PRNewswire/ -- Force Therapeutics has been awarded by Newsweek's World's Best Digital Health Companies 2024 under...
AIRS Medical Secures $20M in Series C Funding to Advance AI-Powered Preventive Healthcare Solutions
SEOUL, South Korea, July 10, 2024 /PRNewswire/ -- AIRS Medical, a pioneering force in artificial intelligence (AI) and robotics for...